Table 1 Antimicrobial activity of the CFS obtained from E. faecalis KT11 against indicator bacteria

Indicator bacteria Inhibition zonesa(mm) Indicator bacteria Inhibition zonesa(mm)
Escherichia coli LMG 8223 -b Lactococcus lactis ssp. cremoris NRRL 634 -
Escherichia coli O157 ATCC 35150 - Leuconostoc mesenteroides ssp. mes. NRRL 1118 15.0±0.8
Klebsiella pneumoniae ATCC 13883 14.0±0.8 Lactobacillus fermentum NRRL 1840 -
Serratia marcescens NRRL 2544 18.0±0.6 Weissella viridescens NRRL 1951 -
Enterobacter aerogenes ATCC 13048 15.0±0.8 Enterococcus faecium NRRL 2354 -
Pseudomonas aeruginosa ATCC 2783 14.0±1.0 Lactobacillus acidophilus NRRL 4495 14.0±0.8
Listeria monocytogenes LMG 13305 15.0±0.5 Lactobacillus plantarum NRRL 4496 -
Bacillus subtilis NRRL NRS 744 15.0±0.8 Staphylococcus epidermidisc (Anadolu Univ.) 20.0±1.4
Bacillus cereus LMG 8221 - Staphylococcus warnerie (Anadolu Univ.) 20.0±1.0
Micrococcus luteus NRRL 1018 16.0±1.6 Staphylococcus aureuse (Anadolu Univ.) -
Staphylococcus aureus ATCC 25923 16.0±1.8 Staphylococcus haemolyticuse (Anadolu Univ.) -
Streptococcus faecalis NRRL 14617 16.0±0.5 Staphylococcus epidermidise (Anadolu Univ.) -
Enterococcus faecalis NRRL 29212 16.0±2.1 Staphylococcus hominisd (Anadolu Univ.) -
Lactobacillus pentosus NRRL 227 - Staphylococcus sp.c (clinical isolate) 15.0±1.0
Lactococcus lactis ssp. lactis NRRL 633 - Enterococcus sp.d (clinical isolate) 17.0±0.8
a Agar well assay was used and wells (8 mm in diameter) were filled with 100 µL CFS samples
b no inhibition
c methicillin-resistant
d vancomycin-resistant
e methicillin and vancomycin-resistant.